Holen Sie sich die Stockscreener-App
23.24
2.70%
0.61
Handel nachbörslich:
23.24
Schlusskurs vom Vortag:
$22.63
Offen:
$22.71
24-Stunden-Volumen:
1.27M
Relative Volume:
1.39
Marktkapitalisierung:
$2.93B
Einnahmen:
$2.12B
Nettoeinkommen (Verlust:
$29.73M
KGV:
131.00
EPS:
0.1774
Netto-Cashflow:
$162.20M
1W Leistung:
-3.13%
1M Leistung:
+0.52%
6M Leistung:
-0.90%
1J Leistung:
-4.36%
1-Tages-Spanne:
$22.46
$23.53
1-Wochen-Bereich:
$22.28
$23.73
52-Wochen-Spanne:
$18.77
$26.51
Privia Health Group Inc Stock (PRVA) Company Profile
Firmenname
Privia Health Group Inc
Sektor
Branche
Telefon
571-366-8850
Adresse
950 N. GLEBE RD., SUITE 700, ARLINGTON
Compare PRVA vs VEEV, BTSG, TEM, HQY, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRVA
Privia Health Group Inc
|
23.24 | 2.85B | 2.12B | 29.73M | 162.20M | 0.1774 |
VEEV
Veeva Systems Inc
|
156.25 | 25.41B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
58.40 | 10.96B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
45.48 | 8.24B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
82.32 | 6.94B | 1.31B | 215.20M | 408.32M | 2.4627 |
HNGE
Hinge Health Inc
|
53.88 | 4.18B | 587.86M | -425.10M | 0 | -5.691 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-01-10 | Eingeleitet | Needham | Buy |
| 2024-12-16 | Eingeleitet | Macquarie | Outperform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Fortgesetzt | Jefferies | Buy |
| 2024-02-22 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-06-13 | Eingeleitet | Evercore ISI | Outperform |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2023-03-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-02-03 | Eingeleitet | Goldman | Buy |
| 2022-12-09 | Eingeleitet | Stifel | Buy |
| 2022-12-08 | Eingeleitet | UBS | Buy |
| 2022-09-07 | Fortgesetzt | Truist | Buy |
| 2022-05-03 | Eingeleitet | BofA Securities | Buy |
| 2022-04-28 | Eingeleitet | BTIG Research | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2022-02-22 | Hochstufung | Cowen | Market Perform → Outperform |
| 2022-01-03 | Eingeleitet | Jefferies | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-05-24 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-05-24 | Eingeleitet | Credit Suisse | Outperform |
| 2021-05-24 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-24 | Eingeleitet | Piper Sandler | Overweight |
| 2021-05-24 | Eingeleitet | Truist | Buy |
| 2021-05-24 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Privia Health Group Inc Aktie (PRVA) Neueste Nachrichten
Privia Health Group's (NASDAQ:PRVA) Earnings May Just Be The Starting Point - simplywall.st
Statutory Profit Doesn't Reflect How Good Privia Health Group's (NASDAQ:PRVA) Earnings Are - Yahoo Finance
Privia Health CEO sells over $2.7m in company stock - Investing.com
Privia Health CEO sells over $2.7m in company stock By Investing.com - Investing.com India
[Form 4] Privia Health Group, Inc. Insider Trading Activity - Stock Titan
Privia Health CFO David Mountcastle sells $76,501 in stock - Investing.com UK
Privia Health CFO David Mountcastle sells $76,501 in stock By Investing.com - Investing.com Nigeria
Privia Health (PRVA) CFO tax-driven sale of 3,385 shares disclosed - Stock Titan
Earnings call transcript: Privia Health Q1 2026 misses EPS but beats revenue By Investing.com - Investing.com South Africa
Earnings call transcript: Privia Health Q1 2026 misses EPS but beats revenue - Investing.com
Privia Health (PRVA) Q1 2026 Earnings Transcript - AOL.com
TradingKey - TradingKey
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
[144] Privia Health Group, Inc. SEC Filing - Stock Titan
A Look At Privia Health Group (PRVA) Valuation After Mixed Recent Share Performance - Sahm
Parth Mehrotra sells PRVA shares, multiple March 2026 transactions (PRVA) - Stock Titan
What to expect from Privia Health’s (PRVA) Q1 earnings - MSN
Affiliate files Form 144 to sell 3,385 shares (PRVA) - Stock Titan
Why Privia Health Group Shares Are Sinking Today - TipRanks
Privia Health Group, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:PRVA) 2026-05-09 - Seeking Alpha
Privia Health Group, Inc. (NASDAQ:PRVA) Q1 2026 Earnings Call Transcript - Insider Monkey
Privia Health Earnings Call Highlights Profitable Growth - TipRanks
Privia Health Group Q1 Earnings Call Highlights - TradingView
Privia Health Group, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Privia Health Q1 2026 slides show operational strength, earnings disappoint By Investing.com - Investing.com Canada
Privia Health: Q1 Earnings Snapshot - theheraldreview.com
Privia Health Group Q1 Profit Squeeze Tests Bullish High P E Narrative - Sahm
Privia Health Q1 2026 slides show operational strength, earnings disappoint - Investing.com
Earnings call transcript: Privia Health Q1 2026 EPS Misses, Revenue Surpasses Forecast - Investing.com
PRVA: Double-digit growth in providers and attributed lives drove strong Q1 results and margin expansion - TradingView
Privia Health (PRVA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Privia Health Group, Inc. 1Q 2026: Revenue $603.85M, EPS $0.02— 10-Q Summary - TradingView
Privia Health (NASDAQ: PRVA) grows Q1 2026 revenue 25.8% to $603.8M - Stock Titan
Privia Health (PRVA) Misses Q1 Earnings Estimates - Yahoo Finance
Privia Health Group Inc (NASDAQ:PRVA) Q1 Revenue Beats Expectations but EPS Misses Weigh on Results - ChartMill
(PRVA) Privia Health Expects 2026 Revenue Range $2.35B$2.45B, vs. FactSet Est of $2.39B - marketscreener.com
Privia Health Group Q1 Non-GAAP Earnings, Revenue Rise; Reaffirms 2026 Revenue Guidance - marketscreener.com
Earnings Flash (PRVA) Privia Health Group, Inc. Reports Q1 Revenue $603.8M, vs. FactSet Est of $561.0M - marketscreener.com
Earnings Flash (PRVA) Privia Health Group, Inc. Posts Q1 Adjusted EPS $0.19 per Share, vs. FactSet Est of $0.24 - marketscreener.com
Privia Health : 1Q'26 conf call script 5 7 26 - marketscreener.com
Privia Health Q1 revenue rises 26%, beats estimates - TradingView
Privia Health (NASDAQ:PRVA) Posts Better-Than-Expected Sales In Q1 CY2026 - Yahoo Finance
PRVA: Q1 revenue up 25.8% year-over-year; guidance raised for Attributed Lives in 2026 - TradingView
Privia Health (Nasdaq: PRVA) posts 25.8% Q1 revenue growth and raises lives outlook - Stock Titan
Privia now expects up to 1.625M covered lives in 2026 - Stock Titan
BRIEF-Privia Health Group Q1 EPS USD 0.02 - TradingView
Privia Health Group, Inc. Maintains Earnings Guidance for the Full Year of 2026 - marketscreener.com
PRVA SEC FilingsPrivia Health Group, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Privia Health earnings on deck as analysts eye provider expansion By Investing.com - Investing.com South Africa
Privia Health earnings on deck as analysts eye provider expansion - Investing.com
Finanzdaten der Privia Health Group Inc-Aktie (PRVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.33%
0.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):